Brucellosis in Cattle: Advances in Diagnosis and Eradication Programs

Introduction

Bovine brucellosis, primarily caused by Brucella abortus, remains a globally significant infectious disease of cattle with profound economic and animal health consequences. The pathogen is a Gram-negative, facultative intracellular coccobacillus that colonizes the reproductive tract of cattle, leading to abortion storms, retained placentas, and reduced milk yield. The chronic nature of infection, coupled with the pathogen's ability to evade host immune responses through intracellular survival within macrophages, complicates both diagnosis and eradication. Eradication programs have historically relied on serological surveillance and test-and-slaughter protocols, but recent advances in molecular diagnostics and immunoproteomics are reshaping the landscape of control strategies. This review examines the biophysical principles of current diagnostic assays, the epidemiological frameworks guiding eradication, and the emerging tools that promise greater specificity and sensitivity in detecting infected herds.

Pathogen Biology and Host Interaction

Brucella abortus exhibits a tropism for placental trophoblasts and mammary tissue in pregnant cattle. The bacterium's lipopolysaccharide (LPS) structure, characterized by a smooth phenotype with O-polysaccharide chains, is a primary target for serological detection. Upon entry through mucosal surfaces, the pathogen is phagocytosed by macrophages and dendritic cells. It survives intracellularly by inhibiting phagolysosome fusion and replicating within the endoplasmic reticulum-derived compartment. This intracellular niche reduces the efficacy of humoral immunity and necessitates cell-mediated immune responses for clearance. The chronic carrier state, often without overt clinical signs in non-pregnant animals, presents a major challenge for eradication. Infected bulls can shed the organism in semen, and vertical transmission occurs through ingestion of contaminated milk or placental material.

Serological Diagnostics

Serological assays remain the cornerstone of bovine brucellosis surveillance due to their scalability and low cost. The principal targets are antibodies directed against the smooth LPS (S-LPS) of Brucella.

Rose Bengal Test (RBT)

The Rose Bengal Test is a rapid agglutination assay performed on serum. A stained Brucella antigen suspension is mixed with serum at a low pH (3.6 to 3.7). The acidic environment reduces non-specific agglutination while preserving specific antibody-antigen interactions. Visible agglutination indicates a positive result. The RBT has high sensitivity but moderate specificity, as cross-reactions with Yersinia enterocolitica O:9 and other Gram-negative bacteria can occur. It is widely used as a screening test in field settings.

Complement Fixation Test (CFT)

The Complement Fixation Test measures the ability of antibodies to fix complement in the presence of Brucella antigen. It is considered a confirmatory test in many eradication programs. The assay involves titration of heat-inactivated serum, addition of a standardized amount of complement, and subsequent lysis of sensitized sheep red blood cells. The absence of hemolysis indicates a positive reaction. The CFT is more specific than the RBT but is technically demanding and subject to prozone effects at high antibody concentrations.

Enzyme-Linked Immunosorbent Assay (ELISA)

Indirect ELISA (iELISA) and competitive ELISA (cELISA) formats are widely used for both serum and milk testing. The iELISA uses purified S-LPS antigen adsorbed to a microtiter plate. Bovine antibodies bind to the antigen and are detected using an anti-bovine IgG conjugate. The cELISA employs a monoclonal antibody specific for a conserved epitope of the S-LPS. The presence of bovine antibodies in the sample competes with the monoclonal antibody, reducing signal. The cELISA offers higher specificity because it reduces cross-reactivity with antibodies against related bacteria. Milk ELISA testing enables non-invasive surveillance at the herd level, as antibodies are concentrated in the milk of infected cows. The diagnostic sensitivity of milk ELISA is comparable to serum ELISA in lactating animals.

Quantum Dot Microspheres Immunochromatographic Assay

A recent innovation in serological testing is the quantum dot microspheres immunochromatographic assay (QDM-ICA) [1]. This platform uses fluorescent quantum dots conjugated to Brucella antigen as the detection probe. The assay is performed on a lateral flow strip. When a serum sample containing anti-Brucella antibodies is applied, the antibodies bind to the quantum dot-antigen conjugates and are captured by immobilized anti-bovine IgG on the test line. The fluorescence intensity of the test line is measured using a portable reader. The QDM-ICA offers quantitative results with a limit of detection comparable to ELISA but with a turnaround time of less than 15 minutes. This technology bridges the gap between laboratory-based ELISA and field-deployable rapid tests.

Molecular Diagnostics

Nucleic acid amplification techniques provide direct detection of Brucella DNA, offering high specificity and the ability to differentiate active infection from past exposure or vaccination.

Conventional and Real-Time PCR

Target genes for PCR assays include the bcsp31 gene (encoding a 31 kDa immunogenic protein), the IS711 insertion element (present in multiple copies in the Brucella genome), and the omp25 gene. Real-time PCR (qPCR) using hydrolysis probes (e.g., TaqMan) enables quantification of bacterial load. The analytical sensitivity of qPCR for Brucella abortus in tissue samples can reach 10 to 100 colony-forming units per gram of tissue. For blood samples, sensitivity is lower due to the intermittent bacteremia characteristic of chronic infection.

Triplex TaqMan qPCR

A triplex TaqMan qPCR assay has been developed for the simultaneous detection of Brucella spp., bovine viral diarrhea virus (BVDV), and Pasteurella multocida in cattle [2]. This assay uses three distinct probe fluorophores (FAM, HEX, and Cy5) targeting the IS711 element for Brucella, the 5' untranslated region for BVDV, and the kmt1 gene for P. multocida. The multiplex format reduces reagent costs and turnaround time while maintaining analytical sensitivity. The assay is particularly useful for differential diagnosis of abortion storms, where multiple pathogens may be involved.

Genome Phylogenetic Analysis

Whole-genome sequencing and phylogenetic analysis of Brucella abortus strains have revealed significant genetic diversity across geographic regions. Analysis of strains isolated from sheep, yak, and cattle in Qinghai, China, demonstrated that strains cluster by host species and geographic origin, with evidence of cross-species transmission [3]. Core genome single nucleotide polymorphism (SNP) analysis provides the resolution needed to trace outbreak sources and distinguish field strains from vaccine strains. This genomic approach is increasingly integrated into eradication programs to identify persistent infection reservoirs.

Eradication Programs: Test-and-Slaughter Strategies

Test-and-slaughter remains the most effective strategy for eliminating bovine brucellosis from a region. The program involves periodic testing of all cattle in a defined population, followed by removal of seropositive animals. The success of this approach depends on high test sensitivity, rapid removal of reactors, and strict movement controls.

Herd-Level Testing Protocols

Herd-level testing typically begins with a screening test such as the RBT or milk ELISA. Positive herds are then subjected to individual animal testing using confirmatory assays (CFT or cELISA). The diagnostic algorithm is designed to maximize positive predictive value in low-prevalence populations. A decision tree for herd-level brucellosis testing is presented below.

graph TD
    A[Herd Screening: RBT or Milk ELISA], > B{Result}
    B, >|Negative| C[Classify as Brucellosis-Free]
    B, >|Positive| D[Individual Animal Testing: CFT or cELISA]
    D, > E{Result}
    E, >|Negative| F[Repeat Herd Test in 60 Days]
    E, >|Positive| G[Slaughter Positive Animals]
    G, > H[Quarantine Herd]
    H, > I[Repeat Herd Test at 30-Day Intervals]
    I, > J{Two Consecutive Negative Herd Tests?}
    J, >|Yes| C
    J, >|No| G

Spatial Epidemiology and Risk Factors

The effectiveness of test-and-slaughter is modulated by spatial and socioeconomic factors. Multiscale geographically weighted regression analysis has identified that herd density, proximity to wildlife reservoirs, and livestock trade networks are significant predictors of brucellosis persistence [4]. In the Northern Province of Sri Lanka, spatial clustering of seropositive herds was associated with smallholder farming systems and lack of biosecurity infrastructure [5]. These findings underscore the need for spatially targeted interventions rather than blanket policies.

Vaccination and DIVA Strategies

Vaccination with live attenuated Brucella abortus strain S19 or RB51 is used in high-prevalence regions to reduce abortion rates and shedding. However, vaccination complicates serological surveillance because S19 induces antibodies that are indistinguishable from those elicited by field infection. The RB51 vaccine, which lacks the O-polysaccharide, does not induce antibodies detectable by standard S-LPS serological tests, enabling differentiation of infected from vaccinated animals (DIVA). However, RB51 is less immunogenic and may require booster doses.

Quantitative proteomics has identified the GntR transcriptional regulator as a novel potential DIVA antigen [6]. GntR is immunogenic in naturally infected cattle but not in RB51-vaccinated animals. Incorporation of GntR into a serological assay could improve the specificity of DIVA testing, allowing continued use of S19 vaccination while maintaining surveillance capacity.

Zoonotic Risk Management

Bovine brucellosis is a zoonotic disease with significant public health implications. Human infection occurs through direct contact with infected tissues, consumption of unpasteurized dairy products, or inhalation of aerosols. In agricultural settings, the risk is highest for veterinarians, slaughterhouse workers, and dairy farmers. A cross-sectional study in wildlife-rich areas of Bolivia, Chile, and Guatemala found that human-animal contact with livestock was a stronger predictor of Brucella seropositivity than contact with wildlife [7]. In Northern Kenya, seroincidence of Brucella spp. infection among humans was correlated with livestock seroprevalence, particularly in pastoralist communities [8].

Eradication programs in cattle directly reduce human exposure by decreasing the prevalence of shedding animals. Test-and-slaughter campaigns in industrial dairy herds have been associated with declining human brucellosis incidence in regions such as Algeria [9] and Changji city, China [10]. A 25-year meta-analysis from Bangladesh confirmed that the temporal trend of Brucella detection in cattle paralleled human case numbers, reinforcing the One Health rationale for livestock-focused interventions [11].

Economic and Nutritional Impact

Chronic brucellosis in cattle has measurable effects on meat quality and nutritional composition. Beef from chronically infected animals shows reduced protein content and altered fatty acid profiles compared to healthy cattle [12]. These changes are attributed to the systemic inflammatory response and metabolic diversion of nutrients toward immune function. The economic losses extend beyond reproductive failure to include carcass condemnation at slaughter and reduced market value of beef products.

Emerging Diagnostic Technologies

Multiplex Molecular Panels

The development of multiplex qPCR assays for simultaneous detection of multiple abortifacient pathogens represents a significant advance. The triplex TaqMan assay for Brucella spp., BVDV, and Pasteurella multocida enables rapid etiological diagnosis of abortion outbreaks [2]. This approach reduces the time to diagnosis from weeks (for bacterial culture) to hours, facilitating timely implementation of control measures.

Point-of-Care Molecular Diagnostics

Isothermal amplification methods such as loop-mediated isothermal amplification (LAMP) and recombinase polymerase amplification (RPA) are being adapted for field detection of Brucella DNA. These assays operate at constant temperatures (60 to 65 degrees Celsius for LAMP, 37 to 42 degrees Celsius for RPA) and do not require thermal cyclers. Detection can be achieved through colorimetric indicators or lateral flow readouts. The portability of these platforms makes them suitable for use in remote livestock markets and smallholder farms.

Immunoproteomic Antigen Discovery

Quantitative proteomics using mass spectrometry has enabled the identification of novel immunodominant antigens for serological diagnosis. The GntR protein, identified through comparative proteomic analysis of Brucella abortus lysates, is recognized by sera from naturally infected cattle but not by sera from RB51-vaccinated animals [6]. This antigen could be incorporated into a multiplex ELISA panel for DIVA testing, improving the specificity of surveillance in vaccinated populations.

Challenges and Future Directions

Despite advances in diagnostics, several challenges impede eradication. The chronic carrier state with intermittent shedding means that single-time-point testing may miss infected animals. Latent infections can reactivate during pregnancy, leading to new abortion events in previously negative herds. The resilience of cattle farmers to infectious disease outbreaks, as measured by psychological and economic coping capacity, is a critical but often overlooked factor in program success [13]. Farmers who perceive the economic burden of test-and-slaughter as unsustainable may delay reporting or avoid testing.

Computational modeling of brucellosis transmission dynamics is increasingly used to optimize eradication strategies. Spatiotemporal models that incorporate livestock movement data, environmental variables, and diagnostic test performance can predict the probability of outbreak persistence and guide resource allocation [14]. The integration of genomic surveillance data with epidemiological models allows real-time tracking of strain introduction and spread.

Conclusion

Bovine brucellosis remains a formidable challenge for veterinary public health, but the convergence of advanced serological platforms, multiplex molecular diagnostics, and immunoproteomic antigen discovery is transforming the diagnostic landscape. Quantum dot immunochromatographic assays offer rapid, quantitative serological testing at the point of care. Triplex qPCR assays enable simultaneous detection of multiple abortifacient pathogens. The identification of DIVA antigens such as GntR promises to reconcile vaccination with serological surveillance. Eradication programs must integrate these tools with spatially targeted interventions and farmer engagement strategies to achieve sustained freedom from infection.

References

[1] Chen M, Yan X, Zhao J, et al. Detection of Bovine Brucellosis Antibodies in Serum and Milk Using Quantum Dot Microspheres Immunochromatographic Assay. Microorganisms. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42197446/

[2] Hu J, Zhou W, Liang S, et al. Epidemiological surveillance of BVDV, Pasteurella multocida, and Brucella spp. infections in cattle from Guizhou, China using a newly established triplex TaqMan qPCR assay. Vet Res Commun. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42113298/

[3] Cao X, Yang Q, Xue H, et al. Identification and Genome Phylogenetic Analysis of Three Brucella abortus Strains From Sheep, Yak, and Cow in Qinghai, China. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253325/

[4] Tian Z, Dong Y, Yuan P, et al. From Global to Local: A Multiscale Geographically Weighted Regression Analysis of Bovine Brucellosis Risk Factors. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42253324/

[5] Sugino Y, Vaseeharan S, Kothalawala KACHA, et al. Spatial epidemiology and socio-economics of bovine brucellosis in selected districts of the Northern Province of Sri Lanka. J Vet Med Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42236214/

[6] Lv H, Liu X, Luo Y, et al. Quantitative proteomics identifies GntR as a novel potential DIVA antigen for bovine brucellosis. Appl Microbiol Biotechnol. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42168698/

[7] Kuhn C, Radon K, Pérez Morales FM, et al. Human-animal contact and zoonotic exposure from wild and domestic animals: A cross-sectional study in wildlife-rich areas of Bolivia, Chile, and Guatemala. One Health. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42183050/

[8] Mwatondo A, Muturi M, Akoko JM, et al. Seroincidence of Brucella spp. infection among humans and livestock in Northern Kenya. Sci Rep. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42178341/

[9] Ghougal K, Azizi A, Laib S, et al. Epidemiological trends and animal-human relationships of brucellosis in Algeria from 2010 to 2022: A one health approach. Comp Immunol Microbiol Infect Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42114331/

[10] Lou P, Huang Y, Fan X, et al. Simulation and prediction of human brucellosis epidemic trends in Changji city. Infect Dis Model. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42211554/

[11] Raquib R, Arnob FA, Hossain R, et al. Prevalence, Associated Factors, and Temporal Trends of Brucella Detection Across Human and Animal Hosts in Bangladesh: A 25-Year Meta-Analysis. Vet Med Sci. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42206877/

[12] Ansabayeva L, Nurgaliyev B, Darmenova A, et al. Veterinary-sanitary evaluation and biochemical quality of beef from cattle with chronic infectious diseases: Impact of chronic brucellosis on nutritional composition. Vet World. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42245466/

[13] Renault V, Delooz L, Humblet MF, et al. Resilience of Belgian Cattle Farmers Towards Infectious Diseases Outbreaks. Transbound Emerg Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42111054/

[14] Yang Q, Zhang N, Shi Y, et al. Spatiotemporal dynamics and serosurveillance landscape of brucellosis at the human-animal interface in the Chinese Southwest: A retrospective study. PLoS Negl Trop Dis. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42213764/

[15] Alamian S, Amiry K, Bahreinipour A, et al. Epidemiological Trends and Strain Distribution of Bovine Brucellosis in Vaccinated Industrial Dairy Cattle (2021-2024). Vet Med Int. 2026. URL: https://pubmed.ncbi.nlm.nih.gov/42148180/